Vasogen-- VAS on TSE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Vasogen-- VAS on TSE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Clarksterh who wrote (327)	8/3/2005 9:18:22 PM
From: Pluvia	Read Replies (1) of 377

Tsk, tsk. Not really fair. Just trying to win the argument by any means. a) It was stat sig for death (if I remember correctly) tisk tisk clark, I suggest you re-read the chf article and go back to your stats 101 class. Specifically this part of the chf article: "the mortality rate is higher than observed (18.9% at 6.5 months) in some recent HF trials..." This strongly suggests that 'improved mortality' was an aberration, as the control group demonstrated higher death rates than is common for a control, thus making the treated group look good. Which is why I pointed out the number of pt's in this trial were too small to produce statistical relevance for mortality. A point anyone who conducts research understands clearly.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next